Magellan Health (MGLN) Tops Q4 EPS by 12c

February 24, 2017 6:35 AM EST

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.80, $0.12 better than the analyst estimate of $1.68. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.33 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings